BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25707578)

  • 21. Cold-induced defects of sodium channel gating in atypical periodic paralysis plus myotonia.
    Webb J; Cannon SC
    Neurology; 2008 Mar; 70(10):755-61. PubMed ID: 17898326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substituted cysteine scanning in D1-S6 of the sodium channel hNav1.4 alters kinetics and structural interactions of slow inactivation.
    Beard JM; Shockett PE; O'Reilly JP
    Biochim Biophys Acta Biomembr; 2020 Feb; 1862(2):183129. PubMed ID: 31738900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Congenital myasthenic syndrome: Correlation between clinical features and molecular diagnosis.
    Estephan EP; Zambon AA; Thompson R; Polavarapu K; Jomaa D; Töpf A; Helito PVP; Heise CO; Moreno CAM; Silva AMS; Kouyoumdjian JA; Morita MDP; Reed UC; Lochmüller H; Zanoteli E
    Eur J Neurol; 2022 Mar; 29(3):833-842. PubMed ID: 34749429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cooperative effect of S4-S5 loops in domains D3 and D4 on fast inactivation of the Na+ channel.
    Popa MO; Alekov AK; Bail S; Lehmann-Horn F; Lerche H
    J Physiol; 2004 Nov; 561(Pt 1):39-51. PubMed ID: 15459238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Na
    Bayless-Edwards L; Winston V; Lehmann-Horn F; Arinze P; Groome JR; Jurkat-Rott K
    Sci Rep; 2018 Jul; 8(1):10372. PubMed ID: 29991727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gating defects of a novel Na+ channel mutant causing hypokalemic periodic paralysis.
    Carle T; Lhuillier L; Luce S; Sternberg D; Devuyst O; Fontaine B; Tabti N
    Biochem Biophys Res Commun; 2006 Sep; 348(2):653-61. PubMed ID: 16890191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced slow inactivation of the human skeletal muscle sodium channel causing normokalemic periodic paralysis.
    Wu L; Zhang B; Kang Y; Wu W
    Cell Mol Neurobiol; 2014 Jul; 34(5):707-14. PubMed ID: 24682880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New Challenges Resulting From the Loss of Function of Na
    Nicole S; Lory P
    Front Pharmacol; 2021; 12():751095. PubMed ID: 34671263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological-genetic features of congenital myasthenic syndrome from a Chinese neuromuscular centre.
    Huang K; Duan HQ; Li QX; Luo YB; Bi FF; Yang H
    J Cell Mol Med; 2022 Jul; 26(14):3828-3836. PubMed ID: 35670010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythromelalgia mutation L823R shifts activation and inactivation of threshold sodium channel Nav1.7 to hyperpolarized potentials.
    Lampert A; Dib-Hajj SD; Eastman EM; Tyrrell L; Lin Z; Yang Y; Waxman SG
    Biochem Biophys Res Commun; 2009 Dec; 390(2):319-24. PubMed ID: 19800314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A sodium channel myotonia due to a novel SCN4A mutation accompanied by acquired autoimmune myasthenia gravis.
    Kokunai Y; Goto K; Kubota T; Fukuoka T; Sakoda S; Ibi T; Doyu M; Mochizuki H; Sahashi K; Takahashi MP
    Neurosci Lett; 2012 Jun; 519(1):67-72. PubMed ID: 22617007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Divalent cation-responsive myotonia and muscle paralysis in skeletal muscle sodium channelopathy.
    Mankodi A; Grunseich C; Skov M; Cook L; Aue G; Purev E; Bakar D; Lehky T; Jurkat-Rott K; Pedersen TH; Childs RW
    Neuromuscul Disord; 2015 Nov; 25(11):908-12. PubMed ID: 26494408
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of S906T polymorphism on the severity of a novel borderline mutation I692M in Na
    Fan C; Mao N; Lehmann-Horn F; Bürmann J; Jurkat-Rott K
    Clin Genet; 2017 Jun; 91(6):859-867. PubMed ID: 27714768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in Resurgent Sodium Current Contribute to the Hyperexcitability of Muscles in Patients with Paramyotonia Congenita.
    Huang CW; Lai HJ; Lin PC; Lee MJ
    Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33430134
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Homozygous C-terminal loss-of-function Na
    Echaniz-Laguna A; Biancalana V; Nadaj-Pakleza A; Fournier E; Matthews E; Hanna MG; Männikkö R
    J Neurol Neurosurg Psychiatry; 2020 Aug; 91(8):898-900. PubMed ID: 32487525
    [No Abstract]   [Full Text] [Related]  

  • 36. Mice with an NaV1.4 sodium channel null allele have latent myasthenia, without susceptibility to periodic paralysis.
    Wu F; Mi W; Fu Y; Struyk A; Cannon SC
    Brain; 2016 Jun; 139(Pt 6):1688-99. PubMed ID: 27048647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotoxin reduces availability of voltage-gated human skeletal muscle sodium channels at depolarized membrane potentials.
    Haeseler G; Foadi N; Wiegand E; Ahrens J; Krampfl K; Dengler R; Leuwer M
    Crit Care Med; 2008 Apr; 36(4):1239-47. PubMed ID: 18379251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New mutation of the Na channel in the severe form of potassium-aggravated myotonia.
    Kubota T; Kinoshita M; Sasaki R; Aoike F; Takahashi MP; Sakoda S; Hirose K
    Muscle Nerve; 2009 May; 39(5):666-73. PubMed ID: 19347921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced availability of voltage-gated sodium channels by depolarization or blockade by tetrodotoxin boosts burst firing and catecholamine release in mouse chromaffin cells.
    Vandael DH; Ottaviani MM; Legros C; Lefort C; Guérineau NC; Allio A; Carabelli V; Carbone E
    J Physiol; 2015 Feb; 593(4):905-27. PubMed ID: 25620605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mutation in SCN4A causes severe myotonia and school-age-onset paralytic episodes.
    Yoshinaga H; Sakoda S; Good JM; Takahashi MP; Kubota T; Arikawa-Hirasawa E; Nakata T; Ohno K; Kitamura T; Kobayashi K; Ohtsuka Y
    J Neurol Sci; 2012 Apr; 315(1-2):15-9. PubMed ID: 22257501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.